Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
主要な著者: | Armstrong, M, Hazlehurst, J, Hull, D, Borrows, S, Guo, K, Yu, J, Barton, D, Gaunt, P, Gough, S, Tomlinson, J, Newsome, P |
---|---|
フォーマット: | Conference item |
出版事項: |
2013
|
類似資料
-
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
著者:: Armstrong, M, 等
出版事項: (2014) -
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
著者:: Armstrong, M, 等
出版事項: (2014) -
Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
著者:: Armstrong, M, 等
出版事項: (2013) -
Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.
著者:: Hazlehurst, J, 等
出版事項: (2013) -
Orlistat for overweight subjects with nonalcoholic steatohepatitis.
著者:: Dowman, J, 等
出版事項: (2009)